Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Clinical trial NCT07566494 · RECRUITING
Trial details
- NCT number
- NCT07566494
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2027-04-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.